×
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
QQQ   283.80 (+0.09%)
AAPL   139.23 (+1.30%)
MSFT   260.26 (+1.47%)
META   163.94 (+2.03%)
GOOGL   2,234.03 (-0.27%)
AMZN   108.92 (+1.42%)
TSLA   685.47 (-1.79%)
NVDA   155.42 (-2.75%)
NIO   21.86 (-2.24%)
BABA   116.03 (-0.63%)
AMD   77.99 (-3.45%)
MU   56.02 (-3.18%)
CGC   3.50 (-3.05%)
T   20.95 (+1.65%)
GE   63.69 (-3.32%)
F   11.52 (-2.46%)
DIS   95.65 (-0.28%)
AMC   13.65 (+2.02%)
PFE   50.94 (+0.55%)
PYPL   71.47 (-0.49%)
NFLX   178.36 (-0.69%)
LON:YGEN

Yourgene Health Share Forecast, Price & News

GBX 6.75
0.00 (0.00%)
(As of 06/29/2022 12:00 AM ET)
Add
Compare
Today's Range
6.50
6.75
50-Day Range
6.68
9.95
52-Week Range
6.32
17.30
Volume
127,449 shs
Average Volume
1.15 million shs
Market Capitalization
£48.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
30 days | 90 days | 365 days | Advanced Chart

Receive YGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yourgene Health and its competitors with MarketBeat's FREE daily newsletter.

YGEN Stock Forecast (MarketRank)

Overall MarketRank

1.05 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.6Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
Yourgene Health logo

About Yourgene Health (LON:YGEN)

Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom, rest of Europe, and internationally. It develops in vitro diagnostic products, such as IONA Test, a non-invasive pre-natal test (NIPT) for Down's syndrome and other genetic disorders in pregnant women; Cystic Fibrosis Screening tests; Rapid Aneuploidy Analysis, a confirmatory diagnostic test carried out after amniocentesi; and Recurrent Pregnancy Loss, a PCR assay for the routine diagnosis of the six most common chromosomes related to pregnancy loss, as well as DPYD genotyping products. The company also offers Ranger, a technology platform for sample size selection and enrichment; Elucigene DPYD assay, a PCR test to predict a patient's response to a chemotherapy treatment; and Clarigene SARS-CoV-2 CE-IVD, a PCR assay used for routine COVID-19 testing. In addition, it provides genomic services; sample preparation and analysis tools; and bioinformatics and software products. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. Yourgene Health Plc was incorporated in 2000 and is headquartered in Manchester, the United Kingdom.

YGEN Stock News Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
180
Year Founded
N/A

Company Calendar

Today
6/29/2022
Next Earnings (Estimated)
8/09/2022

Profitability

P/E Growth
-595.82
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£27.56 million
Cash Flow
GBX 0.62 per share
Book Value
GBX 4.70 per share

Miscellaneous

Free Float
N/A
Market Cap
£48.86 million
Optionable
Not Optionable
Beta
N/A














Yourgene Health Frequently Asked Questions

How has Yourgene Health's stock price performed in 2022?

Yourgene Health's stock was trading at GBX 12.65 at the start of the year. Since then, YGEN stock has decreased by 46.6% and is now trading at GBX 6.75.
View the best growth stocks for 2022 here
.

When is Yourgene Health's next earnings date?

Yourgene Health is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our earnings forecast for Yourgene Health
.

Who are Yourgene Health's key executives?

Yourgene Health's management team includes the following people:
  • Mr. Lyn Dafydd Rees, CEO & Director (Age 48, Pay $299.01k)
  • Mr. Barry Hextall, CFO, Sec. & Exec. Director
  • Mr. Hayden William Jeffreys, COO & Director (Age 47, Pay $186.8k)
  • Dr. Joanne Mason, Chief Scientific Officer & Director (Age 47, Pay $120.82k)
  • Dr. Chia-Han Chang, Chan Ph.D., Chief Entrepreneur & Director (Age 46, Pay $151.34k)
  • Ms. Zoe Crookes, Legal Counsel
  • Ms. Joanne Cross, Director of Marketing
  • Ms. Wendy Cox, HR Director
  • Dr. Michael Risley, Chief Devel. Officer
  • Dr. Matthew Forman, Head of Bioinformatics & Software

What other stocks do shareholders of Yourgene Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include L'Air Liquide (AI), Cerus (CERS), Concepta PLC (CPT.L) (CPT), Alio Gold Inc. (ALO.TO) (ALO), Alamos Gold (AGI), African Gold Group (AGG), Alpha FX Group (AFX), Aminex (AEX), Agnico Eagle Mines (AEM) and Adobe (ADBE).

What is Yourgene Health's stock symbol?

Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN."

How do I buy shares of Yourgene Health?

Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Yourgene Health's stock price today?

One share of YGEN stock can currently be purchased for approximately GBX 6.75.

How much money does Yourgene Health make?

Yourgene Health (LON:YGEN) has a market capitalization of £48.86 million and generates £27.56 million in revenue each year.

How many employees does Yourgene Health have?

Yourgene Health employs 180 workers across the globe.

How can I contact Yourgene Health?

The official website for Yourgene Health is www.yourgene-health.com. The company can be reached via phone at 44 16 1667 6865.

This page (LON:YGEN) was last updated on 6/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.